Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

A new study by UCSF researchers reveals that long-acting injectable treatments offer a promising alternative for HIV patients who find it challenging to adhere to daily pill regimens. This ...

Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Analysis Reveals an Additional Mechanism Behind Statin Therapy's Heart-Related Benefits in People With HIV Dec. 11, 2024 — Investigators who previously found that a daily statin pill helps ...